Literature DB >> 15353493

Upper-extremity deep vein thrombosis: a prospective registry of 592 patients.

Hylton V Joffe1, Nils Kucher, Victor F Tapson, Samuel Z Goldhaber.   

Abstract

BACKGROUND: Upper-extremity deep vein thrombosis (UEDVT) occurs spontaneously or sometimes develops as a complication of pacemaker use, long-term use of a central venous catheter (CVC), or cancer. METHODS AND
RESULTS: To improve our understanding of UEDVT, we compared the demographics, symptoms, risk factors, prophylaxis, and initial management of 324 (6%) patients with central venous catheter (CVC)-associated UEDVT, 268 (5%) patients with non-CVC-associated UEDVT, and 4796 (89%) patients with lower-extremity DVT from a prospective US multicenter DVT registry. The non-CVC-associated UEDVT patients were younger (59.2+/-18.2 versus 64.2+/-16.9 years old; P<0.0001), less often white (65% versus 73%; P<0.01), leaner (body mass index [BMI] 26.8+/-7.1 versus 28.5+/-7.3 kg/m2; P<0.001), and more likely to smoke (19% versus 13%; P=0.02) than the lower-extremity DVT patients. By way of propensity analysis and multivariable logistic regression analysis, we determined that an indwelling CVC was the strongest independent predictor of UEDVT (odds ratio [OR], 7.3; 95% confidence interval [CI], 5.8 to 9.2). An age of <67 years, a BMI of <25 kg/m2, and hospitalization were the independent predictors of non-CVC-associated UEDVT. Most (68%) UEDVT patients were evaluated while they were inpatients. Only 20% of the 378 UEDVT patients who did not have an obvious contraindication to anticoagulation received prophylaxis at the time of diagnosis.
CONCLUSIONS: UEDVT risk factors differ from the conventional risk factors for lower-extremity DVT. Our findings identify deficiencies in our current understanding and the prophylaxis of UEDVT and generate hypotheses for future research efforts.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15353493     DOI: 10.1161/01.CIR.0000142289.94369.D7

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  69 in total

1.  Upper Extremity Deep Vein Thrombosis: The Oft-forgotten Cousin of Venous Thromboembolic Disease.

Authors:  Ronan Margey; Robert M Schainfeld
Journal:  Curr Treat Options Cardiovasc Med       Date:  2011-04

2.  Diagnosis of DVT: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Shannon M Bates; Roman Jaeschke; Scott M Stevens; Steven Goodacre; Philip S Wells; Matthew D Stevenson; Clive Kearon; Holger J Schunemann; Mark Crowther; Stephen G Pauker; Regina Makdissi; Gordon H Guyatt
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

Review 3.  Thrombosis and cancer.

Authors:  Annie Young; Oliver Chapman; Carole Connor; Christopher Poole; Peter Rose; Ajay K Kakkar
Journal:  Nat Rev Clin Oncol       Date:  2012-07-10       Impact factor: 66.675

4.  Soluble P-selectin for the diagnosis of lower extremity deep venous thrombosis.

Authors:  Frank C Vandy; Cathy Stabler; Anna M Eliassen; Angela E Hawley; Kenneth E Guire; Daniel D Myers; Peter K Henke; Thomas W Wakefield
Journal:  J Vasc Surg Venous Lymphat Disord       Date:  2013-04-01

5.  Upper extremity deep vein thrombosis: a community-based perspective.

Authors:  Frederick A Spencer; Cathy Emery; Darleen Lessard; Robert J Goldberg
Journal:  Am J Med       Date:  2007-08       Impact factor: 4.965

6.  Risk factors for venous thrombosis associated with peripherally inserted central venous catheters.

Authors:  Longfang Pan; Qianru Zhao; Xiangmei Yang
Journal:  Int J Clin Exp Med       Date:  2014-12-15

7.  Case report: central venous catheterization via internal jugular vein with associated formation of perioperative venous thrombosis during surgery in the prone position.

Authors:  Kimito Minami; Kimito Mimami; Miki Iida; Hiroki Iida
Journal:  J Anesth       Date:  2012-02-09       Impact factor: 2.078

8.  Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Clive Kearon; Elie A Akl; Anthony J Comerota; Paolo Prandoni; Henri Bounameaux; Samuel Z Goldhaber; Michael E Nelson; Philip S Wells; Michael K Gould; Francesco Dentali; Mark Crowther; Susan R Kahn
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

Review 9.  Paget-Schroetter syndrome: treatment of venous thrombosis and outcomes.

Authors:  Patrick Hangge; Lisa Rotellini-Coltvet; Amy R Deipolyi; Hassan Albadawi; Rahmi Oklu
Journal:  Cardiovasc Diagn Ther       Date:  2017-12

10.  Variability in the management of line-related upper extremity deep vein thrombosis.

Authors:  Rafael Cires-Drouet; Jashank Sharma; Tara McDonald; John D Sorkin; Brajesh K Lal
Journal:  Phlebology       Date:  2019-01-31       Impact factor: 1.740

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.